tirzepatide type 1 diabetes trial in Adults With Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Read now: The SURPASS-EARLY trial

What to look for: Third-party tested purity and potency certifications

This highlights the difference between tirzepatide oral vs injection, and sheds light on why oral tirzepatide vs injectable tirzepatide remains a conversation point with yet many questions unanswered

10.1002/jcsm.13213 12 DongL.XieJ.WangY.JiangH.ChenK.LiD.et al (2022)

,

Non-Blood Flow Dependent : Since it does not rely on blood flow to produce results, PT-141 is an excellent alternative for men with underlying conditions like diabetes or cardiovascular disease

It received FDA approval in 1997 and was considered to be safer than somatropin for treating children with idiopathic growth hormone deficiency